LLA.L,0P0001T9GN,0 Aktie - Unternehmensdaten & Kurse - USU5500L1128 | MoneyPeak

LLA.L,0P0001T9GN,0

Share · USU5500L1128 (XLON)

No Price

n/a

Company Profile for LLA.L,0P0001T9GN,0 Share

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

Get up to date insights from finAgent about LLA.L,0P0001T9GN,0

Company Data

Name LLA.L,0P0001T9GN,0

Company LungLife AI, Inc.

Website https://lunglifeai.com

Primary Exchange

London

ISIN USU5500L1128

Asset Class Share

Sector Healthcare

Industry Medical - Diagnostics & Research

CEO Paul Pagano

Country United States of America

Currency GBX

Employees 0,0 T

Address 2545 West Hillcrest Drive, 91320 Thousand Oaks

IPO Date 2024-06-26

Ticker Symbols

Name	Symbol
London	LLA.L

More Shares

Investors who hold LLA.L,0P0001T9GN,0 also have the following shares in their portfolio:

3M CO 19/22 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025